American Century Companies’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-103,781
Closed -$11.8M 1401
2019
Q1
$11.8M Sell
103,781
-206,582
-67% -$15.2M 0.01% 579
2018
Q4
$12.1M Buy
310,363
+280,174
+928% +$12.2M 0.01% 560
2018
Q3
$1.65M Sell
30,189
-35,014
-54% -$2.39M ﹤0.01% 1048
2018
Q2
$5.4M Buy
65,203
+44,034
+208% +$3.4M 0.01% 840
2018
Q1
$1.41M Buy
21,169
+9,725
+85% +$562K ﹤0.01% 1045
2017
Q4
$588K Sell
11,444
-29,144
-72% -$2.09M ﹤0.01% 1173
2017
Q3
$3.62M Buy
40,588
+39
+0.1% +$2.96K ﹤0.01% 929
2017
Q2
$2.42M Sell
40,549
-447,970
-92% -$25M ﹤0.01% 1007
2017
Q1
$26.1M Buy
488,519
+3,445
+0.7% +$205K 0.03% 478
2016
Q4
$24.2M Buy
485,074
+67,870
+16% +$3.64M 0.03% 493
2016
Q3
$25.1M Buy
417,204
+22,209
+6% +$1.28M 0.03% 487
2016
Q2
$20.2M Buy
394,995
+20,995
+6% +$897K 0.02% 520
2016
Q1
$11M Sell
374,000
-45,203
-11% -$1.43M 0.01% 625
2015
Q4
$19M Buy
419,203
+150,817
+56% +$7.9M 0.02% 514
2015
Q3
$11.2M Buy
268,386
+21,517
+9% +$1.12M 0.01% 622
2015
Q2
$14.9M Buy
246,869
+233,690
+1,773% +$15.5M 0.02% 617
2015
Q1
$1.02M Buy
+13,179
New +$759K ﹤0.01% 1146

Other funds holding ONCE

American Century Companies's ONCE Position: Q2 2019 in Review

American Century Companies sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 103,781 shares — an estimated $11.8M sold.

American Century Companies first reported a position in ONCE in Q1 2015 and held it in 17 quarters. The position peaked at $26.1M in Q1 2017. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

  • American Century Companies reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • American Century Companies sold 103,781 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $11.8M.
  • American Century Companies first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 17 quarters.
  • American Century Companies's Spark Therapeutics, Inc. Common Stock position peaked at $26.1M in Q1 2017.
  • 194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on American Century Companies's 13F filing for Q2 2019, filed 14 Aug 2019.